Immunohistochemical Analysis of IL-6, IL-8/CXCR2 axis, Tyr p -STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: Correlation between microvascular characteristics and prognostic significance

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Levidou, Georgia ^a   Sachanas, Sotirios ^b   Pangalis, Gerassimos A ^b   Kalpadakis, Christina ^c   Yiakoumis, Xanthi ^b   Moschogiannis, Maria ^b   Sepsa, Athanasia ^a   Lakiotaki, Eleftheria ^a   Milionis, Vassilis ^a   Kyrtsonis, Marie Christine ^a   Vassilakopoulos, Theodoros P ^a   Tsirkinidis, Pantelis ^b   Kontopidou, Flora ^a   Kokoris, Styliani ^a   Siakantaris, Marina ^a   Angelopoulou, Maria ^a   Papadaki, Helen ^c   Kavantzas, Nikolaos ^a   Panayiotidis, Panayiotis ^a   Patsouris, Efstratios ^a   Korkolopoulou, Penelope ^a   more..

^a UNIVERSITY OF ATHENS   (Greece)

^b ATHENS MEDICAL CENTER   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 6; INTERLEUKIN 8; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; VASCULOTROPIN; IL6 PROTEIN, HUMAN; SOCS3 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE COUNT; LYMPH NODE; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MORPHOMETRICS; PLASMA CELL; PROTEIN EXPRESSION; TISSUE LEVEL; BIOSYNTHESIS; CELL PROLIFERATION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS;

ADULT; AGED; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, INTERLEUKIN-8B; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901771756     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/251479     Document Type: Article

References (57)

1. Bergers G., Benjamin L. E., Tumorigenesis and the angiogenic switch. Nature Reviews Cancer 2003 3 6 401 410 2-s2.0-0037967272 10.1038/nrc1093 (Pubitemid 37328844)
2. Sachanas S., Angelopoulou M., Korkolopoulou Kalpadakis P., Angiogenesis in chronic lymphocytic leukemia. Current Angiogenesis 2013 2 2 96 103
3. Morais Borges N., Colleoni G. W. B., Angiogenesis and AngiomiRs in Non-Hodgkin's lymphomas. Current Angiogenesis 2012 1 1 20 25 10.2174/2211552811201010020
4. Molica S., Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications. Leukemia & Lymphoma 2001 42 4 603 607 2-s2.0-0034861915 (Pubitemid 32782766)
5. Kay N. E., Bone N. D., Tschumper R. C., Howell K. H., Geyer S. M., Dewald G. W., Hanson C. A., Jelinek D. F., B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. Leukemia 2002 16 5 911 919 2-s2.0-0036099930 10.1038/sj.leu.2402467 (Pubitemid 34537565)
6. Kishimoto T., Interleukin-6: from basic science to medicine-40 years in immunology. Annual Review of Immunology 2005 23 1 21 2-s2.0-17644368573 10.1146/annurev.immunol.23.021704.115806 (Pubitemid 40563163)
7. Ebnet K., Vestweber D., Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochemistry and Cell Biology 1999 112 1 1 23 2-s2.0-0032764894 10.1007/s004180050387 (Pubitemid 29356300)
8. Imada K., Leonard W. J., The Jak-STAT pathway. Molecular Immunology 2000 37 1-2 1 11 2-s2.0-0034023759 10.1016/S0161-5890(00)00018-3 (Pubitemid 30316189)
9. Meinhardt G., Wendtner C.-M., Hallek M., Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. Journal of Molecular Medicine 1999 77 2 282 293 2-s2.0-0033011755 (Pubitemid 29146579)
10. Hazan-Halevy I., Harris D., Liu Z., Liu J., Li P., Chen X., Shanker S., Ferrajoli A., Keating M. J., Estrov Z., STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 2010 115 14 2852 2863 2-s2.0-77951018948 10.1182/blood-2009-10-230060
11. Yu H., Kortylewski M., Pardoll D., Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Reviews Immunology 2007 7 1 41 51 2-s2.0-33845865825 10.1038/nri1995 (Pubitemid 46020826)
12. Rozovski U., Calin G. A., Setoyama T., D'Abundo L., Harris D. M., Li P., Liu Z., Grgurevic S., Ferrajoli A., Faderl S., Burger J. A., O'Brien S., Wierda W. G., Keating M. J., Estrov Z., Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Molecular Cancer 2013 12, article 50 10.1186/1476-4598-12-50
13. Yu H., Jove R., The stats of cancer-new molecular targets come of age. Nature Reviews Cancer 2004 4 2 97 105 2-s2.0-1042302005 (Pubitemid 38198738)
14. Yu H., Pardoll D., Jove R., STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews Cancer 2009 9 11 798 809 2-s2.0-70350500225 10.1038/nrc2734
15. Wormald S., Hilton D. J., Inhibitors of cytokine signal transduction. The Journal of Biological Chemistry 2004 279 2 821 824 2-s2.0-0347093460 10.1074/jbc.R300030200 (Pubitemid 38082600)
16. Lu Y., Fukuyama S., Yoshida R., Kobayashi T., Saeki K., Shiraishi H., Yoshimura A., Takaesu G., Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. The Journal of Biological Chemistry 2006 281 48 36683 36690 2-s2.0-33845992917 10.1074/jbc.M607374200 (Pubitemid 46042135)
17. Zhou H., Miki R., Eeva M., Fike F. M., Seligson D., Yang L., Yoshimura A., Teitell M. A., Jamieson C. A. M., Cacalano N. A., Reciprocal regulation of SOCS1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Clinical Cancer Research 2007 13 8 2344 2353 2-s2.0-34247892414 10.1158/1078-0432.CCR-06-2303 (Pubitemid 46698583)
18. Hu D. E., Hori Y., Fan T.-P. D., Interleukin-8 stimulates angiogenesis in rats. Inflammation 1993 17 2 135 143 2-s2.0-0027404936 (Pubitemid 23105187)
19. Brat D. J., Bellail A. C., van Meir E. G., The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncology 2005 7 2 122 133 2-s2.0-17844397949 10.1215/S1152851704001061 (Pubitemid 40590513)
20. Murphy P. M., Tiffany H. L., Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991 253 5025 1280 1283 2-s2.0-0026018108 (Pubitemid 21917278)
21. Richardson R. M., Marjoram R. J., Barak L. S., Snyderman R., Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. Journal of Immunology 2003 170 6 2904 2911 2-s2.0-0037443490 (Pubitemid 36302161)
22. Swerdlow S. H., Campo E., Harris N. L., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France IARC
23. van Dongen J. J. M., Langerak A. W., Brüggemann M., Evans P. A. S., Hummel M., Lavender F. L., Delabesse E., Davi F., Schuuring E., García-Sanz R., van Krieken J. H. J. M., Droese J., González D., Bastard C., White H. E., Spaargaren M., González M., Parreira A., Smith J. L., Morgan G. J., Kneba M., Macintyre E. A., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003 17 12 2257 2317 2-s2.0-9144265458 10.1038/sj.leu.2403202 (Pubitemid 38072572)
24. Döhner H., Stilgenbauer S., Benner A., Leupolt E., Kröber A., Bullinger L., Döhner K., Bentz M., Lichter P., Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine 2000 343 26 1910 1916 10.1056/NEJM200012283432602 (Pubitemid 32064784)
25. Poeta G. D., Maurillo L., Venditti A., Buccisano F., Epiceno A. M., Capelli G., Tamburini A., Suppo G., Battaglia A., Principe M. I. D., Moro B. D., Masi M., Amadori S., Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001 98 9 2633 2639 2-s2.0-0035525731 10.1182/blood.V98.9.2633
26. Sachanas S., Levidou G., Angelopoulou M., Moschogiannis M., Yiakoumis X., Kalpadakis C. H., Vassilakopoulos T., Kontopidou F., Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of chronic lymphocytic leukemia patients. Leukemia & Lymphoma 2013 55 3 571 582 10.3109/10428194.2013.806802
27. Piperi C., Samaras V., Levidou G., Kavantzas N., Boviatsis E., Petraki K., Grivas A., Barbatis C., Varsos V., Patsouris E., Korkolopoulou P., Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry. Cytokine 2011 55 3 387 395 2-s2.0-79960894174 10.1016/j.cyto.2011.05.012
28. Yan X.-J., Dozmorov I., Li W., Yancopoulos S., Sison C., Centola M., Jain P., Allen S. L., Kolitz J. E., Rai K. R., Chiorazzi N., Sherry B., Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia. Blood 2011 118 19 5201 5210 2-s2.0-81155133323 10.1182/blood-2011-03- 342436
29. Addison C. L., Daniel T. O., Burdick M. D., Liu H., Ehlert J. E., Xue Y. Y., Buechi L., Walz A., Richmond A., Strieter R. M., The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. Journal of Immunology 2000 165 9 5269 5277 2-s2.0-0034327812
30. Rakesh K., Agrawal D. K., Controlling cytokine signaling by constitutive inhibitors. Biochemical Pharmacology 2005 70 5 649 657 2-s2.0-23044500093 10.1016/j.bcp.2005.04.042 (Pubitemid 41058699)
31. di Celle P. F., Carbone A., Marchis D., Zhou D., Sozzani S., Zupo S., Pini M., Mantovani A., Foa R., Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood 1994 84 1 220 228 2-s2.0-0028356439 (Pubitemid 24193824)
32. Biondi A., Rossi V., Bassan R., Barbui T., Bettoni S., Sironi M., Mantovani A., Rambaldi A., Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 1989 73 5 1279 1284 2-s2.0-0024522663 (Pubitemid 19107434)
33. Molica S., Vitelli G., Levato D., Gandolfo G. M., Liso V., Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. British Journal of Haematology 1999 107 3 605 610 2-s2.0-0032705222
34. Fayad L., Keating M. J., Reuben J. M., O'Brien S., Lee B.-N., Lerner S., Kurzrock R., Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001 97 1 256 263 2-s2.0-0035160749 10.1182/blood.V97.1.256 (Pubitemid 32061268)
35. Mihara M., Hashizume M., Yoshida H., Suzuki M., Shiina M., IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clinical Science 2012 122 4 143 159 2-s2.0-84555205600 10.1042/CS20110340
36. Aderka D., Maor Y., Novick D., Engelmann H., Kahn Y., Levo Y., Wallach D., Revel M., Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor- α or-β Blood 1993 81 8 2076 2084 2-s2.0-0027528694 (Pubitemid 23106722)
37. Burger R., Impact of interleukin-6 in hematological malignancies. Transfusion Medicine and Hemotherapy 2013 40 336 3343 10.1159/000354194
38. Attia F., Hassan A., El-Maraghy N., Ibrahium G., Clinical significance of suppressor of cytokines signaling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy. Cancer Biomarkers 2012 11 41 47
39. Matsumoto A., Seki Y.-I., Watanabe R., Hayashi K., Johnston J. A., Harada Y., Abe R., Yoshimura A., Kubo M., A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. Journal of Experimental Medicine 2003 197 4 425 436 2-s2.0-0037450813 10.1084/jem.20020939 (Pubitemid 36278599)
40. Baus D., Pfitzner E., Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells. International Journal of Cancer 2006 118 6 1404 1413 2-s2.0-33644500753 10.1002/ijc.21539
41. Krishnadasan R., Bifulco C., Kim J., Rodov S., Zieske A. W., Vanasse G. J., Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma. British Journal of Haematology 2006 135 1 72 75 2-s2.0-33748343624 10.1111/j.1365-2141.2006.06248.x (Pubitemid 44337665)
42. Stofas A., Levidou G., Piperi C., Adamopoulos C., Bamias A., Karadimou A., Lainakis G., Papadoukakis S., Stravodimos K., Dimopoulos -A M., Patsouris E., Gakiopoulou H., Korkolopoulou P., The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma. BMC Cancer 14, article 149 10.1186/1471-2407-14-149
43. Dolled-Filhart M., Camp R. L., Kowalski D. P., Smith B. L., Rimm D. L., Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Clinical Cancer Research 2003 9 2 594 600 2-s2.0-0037316938 (Pubitemid 36182589)
44. Korkolopoulou P., Levidou G., El-Habr E. A., Adamopoulos C., Samaras V., Zisakis A., Kavantzas N., Boviatsis E., Fragkou P., Papavassiliou A. G., Patsouris E., Piperi C., Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in Astrocytic tumors. Molecular Medicine 2012 18 3 379 388 2-s2.0-84860439625 10.2119/molmed.2011.00449
45. Huang W.-T., Yang S.-F., Wu C.-C., Chen W.-T., Huang Y.-C., Su Y.-C., Chai C.-Y., Expression of signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 in urothelial carcinoma. Kaohsiung Journal of Medical Sciences 2009 25 12 640 645 2-s2.0-71649115559 10.1016/S1607-551X(09) 70569-8
46. Brender C., Nielsen M., Kaltoft K., Mikkelsen G., Zhang Q., Wasik M., Billestrup N., Ødum N., STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. Blood 2001 97 4 1056 1062 2-s2.0-0035865517 10.1182/blood.V97.4.1056 (Pubitemid 32154293)
47. Frater J. L., Kay N. E., Goolsby C. L., Crawford S. E., Dewald G. W., Peterson L. C., Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence. Diagnostic Pathology 2008 3 1, article 16 2-s2.0-43149108875 10.1186/1746-1596-3-16
48. Maffei R., Martinelli S., Castelli I., Santachiara R., Zucchini P., Fontana M., Fiorcari S., Bonacorsi G., Ilariucci F., Torelli G., Marasca R., Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. Leukemia Research 2010 34 3 312 321 2-s2.0-77649190207 10.1016/j.leukres.2009.06.023
49. Gao W., McCormick J., Connolly M., Balogh E., Veale D. J., Fearon U., Hypoxia and STAT3 signalling interactions regulate proinflammatory pathways in rheumatoid arthritis. Annals of the Rheumatic Diseases 2014 10.1136/annrheumdis- 2013-204105
50. Sinha S., Koul N., Dixit D., Sharma V., Sen E., IGF-1 induced HIF-1 α -TLR9 cross talk regulates inflammatory responses in glioma. Cellular Signalling 2011 23 11 1869 1875 2-s2.0-80051473282 10.1016/j.cellsig.2011.06.024
51. Szmigielska-Kapłon A., Lech-Maranda E., Jesionek-Kupnicka D., Gra-Tybor J., Błoski J. Z., Kasznicki M., Kordek R., Robak T., Prognostic value of the bone marrow microvessel density in progressive B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 2010 51 7 1351 1353 2-s2.0-77954127755 10.3109/10428194.2010.486092
52. Kini A. R., Kay N. E., Peterson L. C., Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000 14 8 1414 1418 2-s2.0-0033885493 (Pubitemid 30599322)
53. Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., Koller C., Estrov Z., O'Brien S., Keating M., Freireich E., Albitar M., Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000 96 6 2240 2245 2-s2.0-0034665786
54. Smolej L., Kašparová P., Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. APMIS 2008 116 12 1058 1062 2-s2.0-58149186814 10.1111/j.1600-0463. 2008.00987.x
55. Aguayo A., Manshouri T., O'Brien S., Keating M., Beran M., Koller C., Kantarjian H., Rogers A., Albitar M., Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL). Leukemia Research 2001 25 4 279 285 2-s2.0-0035120088 10.1016/S0145-2126(00) 00139-9 (Pubitemid 32184587)
56. Molica S., Vitelli G., Levato D., Ricciotti A., Digiesi G., Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia. British Journal of Cancer 2002 86 1 31 35 2-s2.0-0037033726 10.1038/sj.bjc.6600022 (Pubitemid 34146337)
57. Aguayo A., O'Brien S., Keating M., Manshouri T., Gidel C., Barlogie B., Beran M., Koller C., Kantarjian H., Albitar M., Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood 2000 96 2 768 770 2-s2.0-18344413014 (Pubitemid 30463404)